KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 79 filers reported holding KRONOS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,040 | -24.4% | 173,877 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $299,068 | +17.8% | 173,877 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $253,860 | +98.0% | 173,877 | +119.7% | 0.00% | +50.0% |
| Q4 2022 | $128,199 | -56.5% | 79,135 | -10.0% | 0.00% | -50.0% |
| Q3 2022 | $295,000 | -76.1% | 87,934 | -74.1% | 0.00% | -78.9% |
| Q2 2022 | $1,235,000 | -10.6% | 339,373 | +77.7% | 0.02% | -13.6% |
| Q1 2022 | $1,381,000 | -67.2% | 191,031 | -38.3% | 0.02% | -63.3% |
| Q4 2021 | $4,207,000 | -59.9% | 309,597 | -38.2% | 0.06% | -64.9% |
| Q3 2021 | $10,493,000 | -12.5% | 500,628 | 0.0% | 0.17% | -23.7% |
| Q2 2021 | $11,990,000 | +117.8% | 500,628 | +166.2% | 0.22% | +83.6% |
| Q1 2021 | $5,505,000 | -16.8% | 188,085 | -15.1% | 0.12% | -30.3% |
| Q4 2020 | $6,616,000 | – | 221,487 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
| Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
| Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
| COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
| Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
| Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
| Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
| Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
| Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |